Back to Agenda
Raising Europe’s Voice in Globalising Regulatory Science
Session Chair(s)
Virginia Acha, PhD, MSc
AVP, Global Regulatory Policy
Merck Sharp & Dohme LLC, United Kingdom
In this session, we aim to take the long view of regulatory science and innovation in establishing the value of medicines and medical treatments, exploring the heritage of European contributions to this scholarship and practice. However, this is undertaken only in the service of the principal goal of this session: to map out the role that Europe could - and should - play in the global evolution of regulation.
Speaker(s)
Panel Discussion
Dimitrios Athanasiou, MBA
WORLD DUCHENNE ORGANIZATION (WDO) , MDA HELLAS, Greece
Patient Advocate
Panel Discussion
Marieke De Bruin, PharmD, PhD
Utrecht Collaborating Centre for Pharmaceutical Policy and Regulation, Netherlands
Scientific Director
Panel Discussion
Sini Eskola, MPharm, MS, MSc
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium
Director Regulatory Affairs
Panel Discussion
Ian Hudson
Bill and Melinda Gates Foundation, United States
Senior Advisor, Integrated Development
Panel Discussion
Tony Humphreys, MPharm
European Medicines Agency, Netherlands
Head of the Regulatory Science and Innovation Task Force
Have an account?